DIRECTOR, CENTER FOR CELL AND GENE THERAPY The primary focus of the Director, Center for Cell and Gene Therapy will be to develop a coordinated institutional effort across clinical services, clinical labs and production facilities involved in transplantation and cell/gene therapy. At Memorial Sloan Kettering Cancer Center (MSKCC) there are currently over 700 bone marrow transplants (BMT), 5 autologous gene-transduced BMTs, and over 100 immune effector cell (IEC) infusions performed annually with significant expected growth over the next five years in both hematological malignancies and solid tumor. The mission of the Center for Cell and Gene Therapy will be to provide a unifying structure across the diverse activities supporting cell-bas